Better adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia

John M. McLaughlin(Pfizer (United States)), Bartholomew J. Tortella(Pfizer (United States)), Michelle Witkop(Munson Medical Center), Angela Lambing(Henry Ford Health System), Terry L. Anderson(Pfizer (United States)), James Munn(University of Michigan)

Haemophilia

February 11, 2014

10.1111/hae.12360

Cited by 62

Related Papers

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

|The Lancet|2021|1.7k

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

|The Lancet|2021|1.3k

Results of the CONTROL Trial: Efficacy and Safety of Recombinant Activated Factor VII in the Management of Refractory Traumatic Hemorrhage

|The Journal of Trauma: Injury, Infection, and Critical Care|2010|347

A Multicenter Study of ICU Telemedicine Reengineering of Adult Critical Care

|CHEST Journal|2014|219

Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis

|Open Forum Infectious Diseases|2022|212